Search

Steven Michael Cernoch

Examiner (ID: 14939, Phone: (571)270-3540 , Office: P/3752 )

Most Active Art Unit
3752
Art Unit(s)
3709, 4114, 3752
Total Applications
834
Issued Applications
420
Pending Applications
79
Abandoned Applications
358

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20378766 [patent_doc_number] => 20250361259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-11-27 [patent_title] => AMORPHOUS FORM OF REDUCED ss-NICOTINAMIDE MONONUCLEOTIDE CALCIUM SALT, AND PREPARATION METHOD AND USE THEREFOR [patent_app_type] => utility [patent_app_number] => 19/262831 [patent_app_country] => US [patent_app_date] => 2025-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19262831 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/262831
AMORPHOUS FORM OF REDUCED ss-NICOTINAMIDE MONONUCLEOTIDE CALCIUM SALT, AND PREPARATION METHOD AND USE THEREFOR Jul 7, 2025 Pending
Array ( [id] => 20005875 [patent_doc_number] => 20250144097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-08 [patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES WITH DIABETES [patent_app_type] => utility [patent_app_number] => 19/003429 [patent_app_country] => US [patent_app_date] => 2024-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 948 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19003429 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/003429
COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES WITH DIABETES Dec 26, 2024 Pending
Array ( [id] => 19916177 [patent_doc_number] => 12291530 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-05-06 [patent_title] => GLP-1R agonist and therapeutic method thereof [patent_app_type] => utility [patent_app_number] => 18/885065 [patent_app_country] => US [patent_app_date] => 2024-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17620 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18885065 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/885065
GLP-1R agonist and therapeutic method thereof Sep 12, 2024 Issued
Array ( [id] => 19570767 [patent_doc_number] => 20240375059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => METAL-ORGANIC FRAMEWORK (MOF)-801@CHITOSAN (CS) PERVAPORATION MEMBRANE AND USE THEREOF IN METHANOL/DIMETHYL CARBONATE SEPARATION [patent_app_type] => utility [patent_app_number] => 18/657820 [patent_app_country] => US [patent_app_date] => 2024-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3958 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 341 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18657820 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/657820
METAL-ORGANIC FRAMEWORK (MOF)-801@CHITOSAN (CS) PERVAPORATION MEMBRANE AND USE THEREOF IN METHANOL/DIMETHYL CARBONATE SEPARATION May 7, 2024 Pending
Array ( [id] => 19403592 [patent_doc_number] => 20240287103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => WATER-REPELLENT PROTECTIVE FILM-FORMING AGENT, WATER-REPELLENT PROTECTIVE FILM-FORMING CHEMICAL SOLUTION, AND WAFER SURFACE TREATMENT METHOD [patent_app_type] => utility [patent_app_number] => 18/583454 [patent_app_country] => US [patent_app_date] => 2024-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10379 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18583454 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/583454
WATER-REPELLENT PROTECTIVE FILM-FORMING AGENT, WATER-REPELLENT PROTECTIVE FILM-FORMING CHEMICAL SOLUTION, AND WAFER SURFACE TREATMENT METHOD Feb 20, 2024 Pending
Array ( [id] => 19359278 [patent_doc_number] => 20240261312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => Method and compositions for treating animal viral infections [patent_app_type] => utility [patent_app_number] => 18/438667 [patent_app_country] => US [patent_app_date] => 2024-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29711 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18438667 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/438667
Method and compositions for treating animal viral infections Feb 11, 2024 Pending
Array ( [id] => 19345157 [patent_doc_number] => 20240254120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => EP4 INHIBITORS AND SYNTHESIS THEREOF [patent_app_type] => utility [patent_app_number] => 18/538687 [patent_app_country] => US [patent_app_date] => 2023-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47956 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18538687 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/538687
EP4 INHIBITORS AND SYNTHESIS THEREOF Dec 12, 2023 Pending
Array ( [id] => 18752560 [patent_doc_number] => 20230355838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => Soft Tissue Filler and Methods [patent_app_type] => utility [patent_app_number] => 18/222106 [patent_app_country] => US [patent_app_date] => 2023-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8598 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18222106 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/222106
Soft Tissue Filler and Methods Jul 13, 2023 Pending
Array ( [id] => 18844653 [patent_doc_number] => 20230407057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => LIQUID COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/334457 [patent_app_country] => US [patent_app_date] => 2023-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11745 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18334457 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/334457
LIQUID COMPOSITION Jun 13, 2023 Pending
Array ( [id] => 18690892 [patent_doc_number] => 20230321054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => COMPOSITIONS AND METHODS FOR CANCER AND TUMOR TREATMENT [patent_app_type] => utility [patent_app_number] => 18/188348 [patent_app_country] => US [patent_app_date] => 2023-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188348 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/188348
COMPOSITIONS AND METHODS FOR CANCER AND TUMOR TREATMENT Mar 21, 2023 Abandoned
Array ( [id] => 19246910 [patent_doc_number] => 20240197894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => RECOMBINANT HUMAN SERUM ALBUMIN-THERAPEUTIC DRUG CONJUGATE [patent_app_type] => utility [patent_app_number] => 18/117661 [patent_app_country] => US [patent_app_date] => 2023-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7223 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18117661 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/117661
RECOMBINANT HUMAN SERUM ALBUMIN-THERAPEUTIC DRUG CONJUGATE Mar 5, 2023 Pending
Array ( [id] => 19359376 [patent_doc_number] => 20240261410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => SODIUM DEOXYCHOLATE BILE ACID AS ANTIBIOTIC CARRIER [patent_app_type] => utility [patent_app_number] => 18/166114 [patent_app_country] => US [patent_app_date] => 2023-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10458 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166114 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/166114
SODIUM DEOXYCHOLATE BILE ACID AS ANTIBIOTIC CARRIER Feb 7, 2023 Pending
Array ( [id] => 18565675 [patent_doc_number] => 20230256002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => Hard lozenge made with dietary fiber [patent_app_type] => utility [patent_app_number] => 18/164837 [patent_app_country] => US [patent_app_date] => 2023-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2474 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164837 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/164837
Hard lozenge made with dietary fiber Feb 5, 2023 Abandoned
Array ( [id] => 19649992 [patent_doc_number] => 12171752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-24 [patent_title] => Methods of treating post-COVID condition(s) [patent_app_type] => utility [patent_app_number] => 18/103983 [patent_app_country] => US [patent_app_date] => 2023-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9945 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18103983 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/103983
Methods of treating post-COVID condition(s) Jan 30, 2023 Issued
Array ( [id] => 18536001 [patent_doc_number] => 20230241088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => COMPOSITION FOR PREVENTING OR TREATING LUNG CANCER COMPRISING ORTHO-TOPOLIN RIBOSIDE AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 18/096575 [patent_app_country] => US [patent_app_date] => 2023-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5494 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18096575 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/096575
COMPOSITION FOR PREVENTING OR TREATING LUNG CANCER COMPRISING ORTHO-TOPOLIN RIBOSIDE AS ACTIVE INGREDIENT Jan 12, 2023 Abandoned
Array ( [id] => 18418498 [patent_doc_number] => 20230172956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => COMBINATORIAL THERAPY FOR USE IN INDUCING IMMUNOGENIC CELL DEATH IN CANCER CELLS [patent_app_type] => utility [patent_app_number] => 18/075621 [patent_app_country] => US [patent_app_date] => 2022-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10346 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18075621 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/075621
Combinatorial therapy for use in inducing immunogenic cell death in cancer cells Dec 5, 2022 Issued
Array ( [id] => 18404533 [patent_doc_number] => 20230165884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => METHOD AND COMPOSITION FOR TREATING ALZHEIMERS [patent_app_type] => utility [patent_app_number] => 18/059383 [patent_app_country] => US [patent_app_date] => 2022-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9659 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18059383 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/059383
METHOD AND COMPOSITION FOR TREATING ALZHEIMERS Nov 27, 2022 Pending
Array ( [id] => 18657674 [patent_doc_number] => 20230303614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/048407 [patent_app_country] => US [patent_app_date] => 2022-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38894 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048407 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/048407
CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF Oct 19, 2022 Pending
Array ( [id] => 18449476 [patent_doc_number] => 20230190752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME [patent_app_type] => utility [patent_app_number] => 18/045744 [patent_app_country] => US [patent_app_date] => 2022-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31837 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045744 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/045744
COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME Oct 10, 2022 Pending
Array ( [id] => 19947063 [patent_doc_number] => 12318401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-03 [patent_title] => Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy [patent_app_type] => utility [patent_app_number] => 17/956701 [patent_app_country] => US [patent_app_date] => 2022-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 21 [patent_no_of_words] => 0 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17956701 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/956701
Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy Sep 28, 2022 Issued
Menu